[{"address1": "4995 Murphy Canyon Road", "address2": "Suite 300", "city": "San Diego", "state": "CA", "zip": "92123", "country": "United States", "phone": "760 471 8536", "website": "https://www.conduitpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. David Joszef Tapolczay", "age": 64, "title": "CEO & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 419799, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Bligh", "age": 34, "title": "Interim CFO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 533345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joanne M. Holland", "age": 48, "title": "Chief Scientific Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  Begien", "title": "Senior VP of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.1533, "open": 0.1544, "dayLow": 0.135, "dayHigh": 0.1562, "regularMarketPreviousClose": 0.1533, "regularMarketOpen": 0.1544, "regularMarketDayLow": 0.135, "regularMarketDayHigh": 0.1562, "beta": 2.169, "volume": 2536403, "regularMarketVolume": 2536403, "averageVolume": 12057750, "averageVolume10days": 12826110, "averageDailyVolume10Day": 12826110, "bid": 0.1396, "ask": 0.1416, "bidSize": 2000, "askSize": 2000, "marketCap": 14717473, "fiftyTwoWeekLow": 0.133, "fiftyTwoWeekHigh": 25.0, "fiftyDayAverage": 0.46604, "twoHundredDayAverage": 2.57264, "currency": "USD", "enterpriseValue": 14736480, "floatShares": 33297310, "sharesOutstanding": 96004704, "sharesShort": 6813303, "sharesShortPriorMonth": 619405, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.071, "heldPercentInsiders": 0.75998, "heldPercentInstitutions": 0.031240001, "shortRatio": 0.23, "impliedSharesOutstanding": 101640000, "bookValue": -0.074, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -5692000, "trailingEps": -0.08, "52WeekChange": -0.9856755, "SandP52WeekChange": 0.24059486, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CDT", "underlyingSymbol": "CDT", "shortName": "Conduit Pharmaceuticals Inc.", "longName": "Conduit Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1648474200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a0dccb0b-a2b5-3d84-a45d-30dad465afbd", "messageBoardId": "finmb_1772079937", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.1448, "recommendationKey": "none", "totalCash": 433000, "totalCashPerShare": 0.005, "totalDebt": 1268000, "quickRatio": 0.217, "currentRatio": 0.561, "returnOnAssets": -3.22017, "operatingCashflow": -9197000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-29"}]